Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
- 21-Nov-24
Select bar for recommendation details.
Recommendations | 21-Nov-24 | |
---|---|---|
Buy | 1 | |
Outperform | 1 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in CAD
The 2 analysts offering 12 month price targets for Eupraxia Pharmaceuticals Inc have a median target of 12.38, with a high estimate of 16.50 and a low estimate of 8.25. The median estimate represents a 161.73% increase from the last price of 4.73.
High | 248.8% | 16.50 |
Med | 161.7% | 12.38 |
Low | 74.4% | 8.25 |
Earnings history & estimates in CAD
The next earnings announcement is expected on Mar 24, 2025.
Average growth rate | -2.09% |
Average growth rate | +19.47% |
More ▼
Revenue history & estimates in CAD
Average growth rate | 0.00% |
Average growth rate | 0.00% |
More ▼